Bipolar Disorder Trial, Recruiting NCT03601026 Sponsor: Nova Scotia Health Authority Condition: Bipolar Disorder
Back to Bipolar Disorder

Bipolar Disorder Trial, Recruiting

NCT03601026
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are already enrolled in a study called FORBOW (Families Overcoming Risks and Building Opportunities for Well-being).
  • People between the ages of 12 and 21 years old.
  • People with enough understanding of English to take part in and benefit from the program.
  • People who showed the ability to give informed consent at their most recent FORBOW check-in.
  • People who agreed to be contacted about future studies at their most recent FORBOW check-in.

Who may not be able to join:

  • People who have already been diagnosed with a severe mental illness — such as a psychotic disorder, bipolar disorder, or severe or recurring depression — at the start of the trial.
  • People with autism or an intellectual disability that significantly affects their ability to complete assessments (generally indicated by an IQ score below 70).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Rudolf Uher, MD, PhD, Nova Scotia Health Authority, Dalhousie University

Phone: 902-473-7209

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Nova Scotia Health Authority
Registry
ClinicalTrials.gov
Start date
1 November 2019
Est. completion
1 September 2026

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Self-reported cannabis use

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov